SHARE-BASED COMPENSATION (SARS Activity) (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)	12 Months Ended
	Jan. 28, 2023	Jan. 29, 2022	Jan. 30, 2021
Number of Underlying Shares Outstanding [Roll Forward]
Number of Underlying Shares, Outstanding (in shares)	190,589	236,139
Number of Underlying Shares, Granted (in shares)	0
Number of Underlying Shares, Exercised (in shares)	(4,350)
Number of Underlying Shares, Forfeited or expired (in shares)	(41,200)
Weighted-Average Exercise Price [Roll Forward]
Weighted-Average Exercise Price, Outstanding (in dollars per share)	$ 29.43	$ 32.55
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)	0
Weighted-Average Exercise Price, Exercised (in dollars per share)	22.46
Weighted-Average Exercise Price, Forfeited or exercised (in dollars per share)	$ 48.06
Aggregate Intrinsic Value, Outstanding	$ 1,262
Weighted-Average Remaining Contractual Life, Outstanding	1 year 8 months 12 days
Number of Underlying Shares, Stock appreciation rights exercisable (in shares)	190,589
Weighted-Average Exercise Price, Stock appreciation rights exercisable (in dollars per share)	$ 29.43
Aggregate Intrinsic Value, Stock appreciation rights exercisable	$ 1,262
Weighted- Average Remaining Contractual Life, Stock appreciation rights exercisable	1 year 8 months 12 days
Grant date fair value of award other than options vested during period	$ 0	$ 1,069,000	$ 0